Urothelial Carcinoma Methods and Protocols /

Urothelial Carcinoma Methods and Protocols /

Show other versions (1)
Bibliographic Details
Corporate Author: SpringerLink (Online service)
Other Authors: Hoffmann, Michèle J. (Editor), Gaisa, Nadine T. (Editor), Nawroth, Roman (Editor), Ecke, Thorsten H. (Editor)
Summary:XI, 331 p. 55 illus., 51 illus. in color.
text
Language:English
Published: New York, NY : Springer US : Imprint: Humana, 2023.
Edition:2nd ed. 2023.
Series:Methods in Molecular Biology, 2684
Subjects:
Cancer.
Tumor markers.
Cancer Biology.
Tumour Biomarkers.
Online Access:https://doi.org/10.1007/978-1-0716-3291-8
Format: Electronic Book
Table of Contents:
  • Scoring Systems for Immunohistochemistry in Urothelial Carcinoma
  • A Panel-Based Method for the Reproduction of Distinct Molecular Subtype Classifications of Muscle-Invasive Urothelial Bladder Cancer
  • Analysis of Mutational Signatures Using the mutSignatures R Library
  • A Drug Repurposing Pipeline Based on Bladder Cancer Integrated Proteotranscriptomics Signatures
  • Characterization of Native COMPASS Complex in Urothelial Carcinoma Cells by Size Exclusion Chromatography
  • Reconstructing Phylogenetic Relationship in Bladder Cancer: A Methodological Overview
  • Using Sister Chromatid Exchange Assay to Detect Homologous Recombination Deficiency in Epigenetically Deregulated Urothelial Carcinoma Cells
  • Identification of STAG2 Mutant Bladder Cancers by Immunohistochemistry
  • Genome-Wide CRISPR Screening for the Identification of Therapy-Resistance-Associated Genes in Urothelial Carcinoma
  • Tissue Slice Culture and Analysis of Tumor-Associated Hyaluronan in Urothelial Carcinoma
  • NGS-Based Tumor-Informed Analysis of Circulating Tumor DNA
  • Considering the Effects of Modern Point-of-Care Urine Biomarker Assays in Follow-Up of Patients with High-Risk Non-Muscle Invasive Bladder Cancer
  • Simplex Droplet Digital PCR Assays for the Detection of TERT Promoter Mutations in Urine Samples for the Non-Invasive Diagnosis of Urothelial Cancer
  • Predictive Biomarkers of Response to Neoadjuvant Therapy in Muscle Invasive Bladder Cancer
  • Assessment of PD-L1 Status in Urothelial Cancer
  • Epigenetic Priming and Development of New Combination Therapy Approaches
  • Evaluation of FGFR Alteration Status in Urothelial Tumors
  • Antibody-Drug-Conjugates (ADC): A Novel Treatment Option in Urothelial Carcinoma
  • Intravesical Infusion of Oncolytic Virus CG0070 in the Treatment of Bladder Cancer
  • Analysis of ICAM-1 Expression on Bladder Carcinoma Cell Lines and Infectivity and Oncolysisby Coxsackie Virus A21.

Similar Items